Lhermitte's sign following chemotherapy with docetaxel

Neurology. 1998 Feb;50(2):563-4. doi: 10.1212/wnl.50.2.563.

Abstract

Specific causes for Lhermitte's sign (LS) in cancer patients are spinal cord compression, radiation therapy to the spinal cord, and cisplatin chemotherapy. We observed a transient LS in five of 87 patients treated with more than two cycles of 100 mg/m2 docetaxel (Taxotere). LS developed either concurrently or after the onset of docetaxel-induced sensory neuropathy, and disappeared after the discontinuation or dose reduction of chemotherapy.

Publication types

  • Case Reports
  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Adult
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Docetaxel
  • Female
  • Humans
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neoplasms / drug therapy*
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects
  • Paclitaxel / analogs & derivatives*
  • Spinal Cord / pathology
  • Spinal Cord Diseases / chemically induced*
  • Spinal Cord Diseases / diagnosis
  • Taxoids*

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel
  • Paclitaxel